Review



dce-mri data processing  (Philips Healthcare)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Philips Healthcare dce-mri data processing
    Dce Mri Data Processing, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce-mri+data+processing/dce+mri/pm40311273-69-1-6
    Average 90 stars, based on 1 article reviews
    dce-mri data processing - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Magnetic Resonance Imaging:

    Article Title: Contrast-enhanced orbital MRI for activity assessment and treatment response prediction in thyroid eye disease.
    Article Snippet: Objective: To investigate the performance of contrast-enhanced orbital MRI (T1-weighted contrast-enhanced [T1CE] and dynamic contrast-enhanced MRI [DCE-MRI]) for activity assessment and prediction of treatment response to intravenous glucocorticoid (IVGC) treatment in thyroid eye disease (TED).. Methods: A retrospective study of 59 active moderate-to-severe TED patients (36 responsive and 23 unresponsive) treated with IVGC, matched with 31 inactive TED patients were included.. T1CE and DCE-MRI were collected from each subject.

    Article Title: Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model.
    Article Snippet: All DCE-MRI images were processed in Philips Intellispace (version 10.1, Philips Medical Systems Nederland B.V., Best, The Netherlands).

    Article Title: Evaluation of blood supply using dynamic contrast-enhanced magnetic resonance imaging and its application in spinal tumor surgery.
    Article Snippet: Objective: This study aimed to assess the utility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in evaluating blood supply for spinal tumors and its predictive value for intraoperative blood loss and transfusion requirements during spinal tumor surgery.. Methods:We retrospectively analyzed clinical data from 20 patients with single vertebral tumors who underwent surgery at the Affiliated Hospital of Hebei University of Technology between December 2018 and December 2020.. Patients were categorized based on DCE-MRI into two groups: those with tumors indicating rich blood supply (15 patients, with 12 undergoing preoperative embolization) and those with non-rich blood supply tumors (5 patients, without embolization).

    Article Title: Galunisertib promotes bevacizumab-induced vascular normalization in nasopharyngeal carcinoma: Multi-parameter MRI evaluation
    Article Snippet: The DCE-MRI images were processed by IntelliSpace Portal 9.0 software (ISP, Philips).

    Article Title: Fibroglandular tissue segmentation in breast MRI using vision transformers: a multi-institutional evaluation.
    Article Snippet: Dynamic contrast-enhanced (DCE)-MRI of the breasts was conducted according to a standardized protocol22 at a 1.5-T (Achieva and Ingenia; Philips Medical Systems) with a double-breast four-element surface coil (Invivo).

    Article Title: Characterization of denosumab treatment response in giant cell tumors of bone with dynamic contrast-enhanced MRI.
    Article Snippet: All DCE-MRI images were processed in Philips IntelliSpace Portal (version 12, Philips Medical Systems) and segmented by a dedicated musculoskeletal oncology radiologist (5 years of experience).

    Article Title: Comprehensive Analysis of ADAMTS Gene Family in Renal Clear Cell Carcinoma and ADAMTS10 Research Combining Magnetic Resonance Imaging.
    Article Snippet: With the informed consent of the patient, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion weighted imaging (DWI) (PHILIPS-Achieva 1.5T superconducting magnetic resonance imaging instrument, Philips, Netherlands) were performed within 1 week to collect information on renal short T2 signal tumor lesions before surgery.

    Article Title: Fibroglandular tissue segmentation in breast MRI using vision transformers: a multi-institutional evaluation
    Article Snippet: Dynamic contrast-enhanced (DCE)-MRI of the breasts was conducted according to a standardized protocol at a 1.5-T (Achieva and Ingenia; Philips Medical Systems) with a double-breast four-element surface coil (Invivo).

    Diffusion-based Assay:

    Article Title: Contrast-enhanced orbital MRI for activity assessment and treatment response prediction in thyroid eye disease.
    Article Snippet: Objective: To investigate the performance of contrast-enhanced orbital MRI (T1-weighted contrast-enhanced [T1CE] and dynamic contrast-enhanced MRI [DCE-MRI]) for activity assessment and prediction of treatment response to intravenous glucocorticoid (IVGC) treatment in thyroid eye disease (TED).. Methods: A retrospective study of 59 active moderate-to-severe TED patients (36 responsive and 23 unresponsive) treated with IVGC, matched with 31 inactive TED patients were included.. T1CE and DCE-MRI were collected from each subject.

    Article Title: Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model.
    Article Snippet: All DCE-MRI images were processed in Philips Intellispace (version 10.1, Philips Medical Systems Nederland B.V., Best, The Netherlands).

    Article Title: Evaluation of blood supply using dynamic contrast-enhanced magnetic resonance imaging and its application in spinal tumor surgery.
    Article Snippet: Objective: This study aimed to assess the utility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in evaluating blood supply for spinal tumors and its predictive value for intraoperative blood loss and transfusion requirements during spinal tumor surgery.. Methods:We retrospectively analyzed clinical data from 20 patients with single vertebral tumors who underwent surgery at the Affiliated Hospital of Hebei University of Technology between December 2018 and December 2020.. Patients were categorized based on DCE-MRI into two groups: those with tumors indicating rich blood supply (15 patients, with 12 undergoing preoperative embolization) and those with non-rich blood supply tumors (5 patients, without embolization).

    Article Title: Galunisertib promotes bevacizumab-induced vascular normalization in nasopharyngeal carcinoma: Multi-parameter MRI evaluation
    Article Snippet: The DCE-MRI images were processed by IntelliSpace Portal 9.0 software (ISP, Philips).

    Article Title: Fibroglandular tissue segmentation in breast MRI using vision transformers: a multi-institutional evaluation.
    Article Snippet: Dynamic contrast-enhanced (DCE)-MRI of the breasts was conducted according to a standardized protocol22 at a 1.5-T (Achieva and Ingenia; Philips Medical Systems) with a double-breast four-element surface coil (Invivo).

    Article Title: Characterization of denosumab treatment response in giant cell tumors of bone with dynamic contrast-enhanced MRI.
    Article Snippet: All DCE-MRI images were processed in Philips IntelliSpace Portal (version 12, Philips Medical Systems) and segmented by a dedicated musculoskeletal oncology radiologist (5 years of experience).

    Article Title: Comprehensive Analysis of ADAMTS Gene Family in Renal Clear Cell Carcinoma and ADAMTS10 Research Combining Magnetic Resonance Imaging.
    Article Snippet: With the informed consent of the patient, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion weighted imaging (DWI) (PHILIPS-Achieva 1.5T superconducting magnetic resonance imaging instrument, Philips, Netherlands) were performed within 1 week to collect information on renal short T2 signal tumor lesions before surgery.

    Article Title: Fibroglandular tissue segmentation in breast MRI using vision transformers: a multi-institutional evaluation
    Article Snippet: Dynamic contrast-enhanced (DCE)-MRI of the breasts was conducted according to a standardized protocol at a 1.5-T (Achieva and Ingenia; Philips Medical Systems) with a double-breast four-element surface coil (Invivo).

    Imaging:

    Article Title: Contrast-enhanced orbital MRI for activity assessment and treatment response prediction in thyroid eye disease.
    Article Snippet: Objective: To investigate the performance of contrast-enhanced orbital MRI (T1-weighted contrast-enhanced [T1CE] and dynamic contrast-enhanced MRI [DCE-MRI]) for activity assessment and prediction of treatment response to intravenous glucocorticoid (IVGC) treatment in thyroid eye disease (TED).. Methods: A retrospective study of 59 active moderate-to-severe TED patients (36 responsive and 23 unresponsive) treated with IVGC, matched with 31 inactive TED patients were included.. T1CE and DCE-MRI were collected from each subject.

    Article Title: Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model.
    Article Snippet: All DCE-MRI images were processed in Philips Intellispace (version 10.1, Philips Medical Systems Nederland B.V., Best, The Netherlands).

    Article Title: Evaluation of blood supply using dynamic contrast-enhanced magnetic resonance imaging and its application in spinal tumor surgery.
    Article Snippet: Objective: This study aimed to assess the utility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in evaluating blood supply for spinal tumors and its predictive value for intraoperative blood loss and transfusion requirements during spinal tumor surgery.. Methods:We retrospectively analyzed clinical data from 20 patients with single vertebral tumors who underwent surgery at the Affiliated Hospital of Hebei University of Technology between December 2018 and December 2020.. Patients were categorized based on DCE-MRI into two groups: those with tumors indicating rich blood supply (15 patients, with 12 undergoing preoperative embolization) and those with non-rich blood supply tumors (5 patients, without embolization).

    Article Title: Galunisertib promotes bevacizumab-induced vascular normalization in nasopharyngeal carcinoma: Multi-parameter MRI evaluation
    Article Snippet: The DCE-MRI images were processed by IntelliSpace Portal 9.0 software (ISP, Philips).

    Article Title: Fibroglandular tissue segmentation in breast MRI using vision transformers: a multi-institutional evaluation.
    Article Snippet: Dynamic contrast-enhanced (DCE)-MRI of the breasts was conducted according to a standardized protocol22 at a 1.5-T (Achieva and Ingenia; Philips Medical Systems) with a double-breast four-element surface coil (Invivo).

    Article Title: Characterization of denosumab treatment response in giant cell tumors of bone with dynamic contrast-enhanced MRI.
    Article Snippet: All DCE-MRI images were processed in Philips IntelliSpace Portal (version 12, Philips Medical Systems) and segmented by a dedicated musculoskeletal oncology radiologist (5 years of experience).

    Article Title: Comprehensive Analysis of ADAMTS Gene Family in Renal Clear Cell Carcinoma and ADAMTS10 Research Combining Magnetic Resonance Imaging.
    Article Snippet: With the informed consent of the patient, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion weighted imaging (DWI) (PHILIPS-Achieva 1.5T superconducting magnetic resonance imaging instrument, Philips, Netherlands) were performed within 1 week to collect information on renal short T2 signal tumor lesions before surgery.

    Article Title: Fibroglandular tissue segmentation in breast MRI using vision transformers: a multi-institutional evaluation
    Article Snippet: Dynamic contrast-enhanced (DCE)-MRI of the breasts was conducted according to a standardized protocol at a 1.5-T (Achieva and Ingenia; Philips Medical Systems) with a double-breast four-element surface coil (Invivo).



    Similar Products

    dce-mri data processing  (Philips Healthcare)
    90
    Philips Healthcare dce-mri data processing
    Dce Mri Data Processing, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce-mri+data+processing/dce+mri/pm40311273-69-1-6
    Average 90 stars, based on 1 article reviews
    dce-mri data processing - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    the processing software for all of the quantitative analyses of the data obtained by dce- and ssce-mri  (MathWorks Inc)
    90
    MathWorks Inc the processing software for all of the quantitative analyses of the data obtained by dce- and ssce-mri
    In vivo rVDI and rVSI maps and quantitative curves for tumor xenografts of CL1-0 cancer cells overexpressing one of three VEGF isoforms, evaluated by <t>SSCE-MRI.</t> Representative high-resolution maps of the (A) rVDI and (B) rVSI in the different VEGF-overexpressing and mock tumors on day 36 after tumor implantation. In rVDI map, the color ranged from blue (0 S -1/3 , lowest rVDI) to red (0.4 S -1/3 , highest rVDI). In rVSI map, the color ranged from blue (0, lowest rVSI) to red (30, highest rVSI).Quantitative analysis of (C) rVDI and (D) rVSI in the whole tumor (upper), tumor rim (middle), or tumor core (lower). Differences between VEGF-overexpressing tumors and mock tumors were significant at the * p <0.05, ** p <0.01, *** p <0.001, and **** p <0.0001 levels.
    The Processing Software For All Of The Quantitative Analyses Of The Data Obtained By Dce And Ssce Mri, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce-mri+data+processing/software+dce+ssce+mri/pmc03024413-174-16-20
    Average 90 stars, based on 1 article reviews
    the processing software for all of the quantitative analyses of the data obtained by dce- and ssce-mri - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    dce-mri data processing  (MathWorks Inc)
    90
    MathWorks Inc dce-mri data processing
    In vivo rVDI and rVSI maps and quantitative curves for tumor xenografts of CL1-0 cancer cells overexpressing one of three VEGF isoforms, evaluated by <t>SSCE-MRI.</t> Representative high-resolution maps of the (A) rVDI and (B) rVSI in the different VEGF-overexpressing and mock tumors on day 36 after tumor implantation. In rVDI map, the color ranged from blue (0 S -1/3 , lowest rVDI) to red (0.4 S -1/3 , highest rVDI). In rVSI map, the color ranged from blue (0, lowest rVSI) to red (30, highest rVSI).Quantitative analysis of (C) rVDI and (D) rVSI in the whole tumor (upper), tumor rim (middle), or tumor core (lower). Differences between VEGF-overexpressing tumors and mock tumors were significant at the * p <0.05, ** p <0.01, *** p <0.001, and **** p <0.0001 levels.
    Dce Mri Data Processing, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce-mri+data+processing/pmc03102848-71-0-7
    Average 90 stars, based on 1 article reviews
    dce-mri data processing - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    In vivo rVDI and rVSI maps and quantitative curves for tumor xenografts of CL1-0 cancer cells overexpressing one of three VEGF isoforms, evaluated by SSCE-MRI. Representative high-resolution maps of the (A) rVDI and (B) rVSI in the different VEGF-overexpressing and mock tumors on day 36 after tumor implantation. In rVDI map, the color ranged from blue (0 S -1/3 , lowest rVDI) to red (0.4 S -1/3 , highest rVDI). In rVSI map, the color ranged from blue (0, lowest rVSI) to red (30, highest rVSI).Quantitative analysis of (C) rVDI and (D) rVSI in the whole tumor (upper), tumor rim (middle), or tumor core (lower). Differences between VEGF-overexpressing tumors and mock tumors were significant at the * p <0.05, ** p <0.01, *** p <0.001, and **** p <0.0001 levels.

    Journal: PLoS ONE

    Article Title: Functional and Structural Characteristics of Tumor Angiogenesis in Lung Cancers Overexpressing Different VEGF Isoforms Assessed by DCE- and SSCE-MRI

    doi: 10.1371/journal.pone.0016062

    Figure Lengend Snippet: In vivo rVDI and rVSI maps and quantitative curves for tumor xenografts of CL1-0 cancer cells overexpressing one of three VEGF isoforms, evaluated by SSCE-MRI. Representative high-resolution maps of the (A) rVDI and (B) rVSI in the different VEGF-overexpressing and mock tumors on day 36 after tumor implantation. In rVDI map, the color ranged from blue (0 S -1/3 , lowest rVDI) to red (0.4 S -1/3 , highest rVDI). In rVSI map, the color ranged from blue (0, lowest rVSI) to red (30, highest rVSI).Quantitative analysis of (C) rVDI and (D) rVSI in the whole tumor (upper), tumor rim (middle), or tumor core (lower). Differences between VEGF-overexpressing tumors and mock tumors were significant at the * p <0.05, ** p <0.01, *** p <0.001, and **** p <0.0001 levels.

    Article Snippet: The processing software for all of the quantitative analyses of the data obtained by DCE- and SSCE-MRI was written in MATLAB (MathWorks, Natick, MA, USA).

    Techniques: In Vivo, Tumor Implantation